Sale!

BCS1L Gene GRACILE Syndrome NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The BCS1L Gene GRACILE Syndrome NGS Genetic DNA Test is a comprehensive diagnostic tool that identifies mutations in the BCS1L gene associated with GRACILE syndrome, a severe mitochondrial disorder affecting newborns. This advanced next-generation sequencing test provides precise detection of genetic variants responsible for this rare condition characterized by growth retardation, aminoaciduria, cholestasis, iron overload, lactic acidosis, and early death. The test is crucial for families with a history of mitochondrial disorders or infants showing symptoms of metabolic dysfunction. Results help guide medical management, inform family planning decisions, and provide definitive diagnosis for affected individuals. Available for $500 USD with professional genetic counseling included.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

BCS1L Gene GRACILE Syndrome NGS Genetic DNA Test

Comprehensive Genetic Testing for Mitochondrial Disorders

The BCS1L Gene GRACILE Syndrome NGS Genetic DNA Test represents a cutting-edge diagnostic approach for identifying mutations in the BCS1L gene, which plays a critical role in mitochondrial function and energy production within cells. This specialized genetic test utilizes next-generation sequencing technology to provide comprehensive analysis of the BCS1L gene, enabling accurate detection of variants associated with GRACILE syndrome—a severe autosomal recessive mitochondrial disorder that primarily affects infants and young children.

What Does This Test Measure and Detect?

This advanced genetic screening test specifically targets the BCS1L gene, which encodes a mitochondrial protein essential for the proper assembly of complex III in the mitochondrial respiratory chain. The test detects:

  • Pathogenic variants and mutations in the BCS1L gene
  • Single nucleotide polymorphisms (SNPs) associated with GRACILE syndrome
  • Insertions, deletions, and copy number variations affecting gene function
  • Compound heterozygous and homozygous mutations
  • Novel variants of uncertain significance requiring further clinical correlation

Who Should Consider This Genetic Test?

This specialized genetic testing is recommended for individuals and families experiencing:

  • Infants presenting with failure to thrive and growth retardation
  • Newborns with unexplained lactic acidosis and metabolic disturbances
  • Children showing signs of hepatic dysfunction including cholestasis
  • Patients with abnormal iron metabolism and elevated ferritin levels
  • Families with a history of mitochondrial disorders or unexplained infant deaths
  • Couples with previous affected children planning future pregnancies
  • Individuals with aminoaciduria and renal tubular dysfunction

Clinical Benefits of BCS1L Genetic Testing

Undergoing this comprehensive genetic analysis provides numerous clinical advantages:

  • Definitive Diagnosis: Provides conclusive identification of GRACILE syndrome, eliminating diagnostic uncertainty
  • Family Planning Guidance: Enables informed reproductive decisions for at-risk couples
  • Early Intervention: Facilitates timely medical management and supportive care strategies
  • Genetic Counseling: Supports comprehensive family risk assessment and education
  • Research Contribution: Advances understanding of mitochondrial disorders and potential treatments
  • Prenatal Testing: Allows for early detection in subsequent pregnancies when indicated

Understanding Your Test Results

Your genetic test results will be carefully interpreted by our team of certified genetic counselors and medical geneticists:

  • Positive Result: Indicates the presence of pathogenic mutations in the BCS1L gene, confirming GRACILE syndrome diagnosis
  • Negative Result: Suggests absence of known disease-causing variants in the BCS1L gene
  • Variant of Uncertain Significance: Identifies genetic changes with unclear clinical implications requiring further evaluation
  • Carrier Status: Determines if an individual carries one copy of a mutated gene without showing symptoms

All results include detailed explanations and recommendations for next steps, including appropriate medical follow-up and family testing considerations.

Test Pricing and Availability

Test Component Price (USD)
Discount Price $500
Regular Price $700

Nationwide Testing Availability

We proudly offer comprehensive genetic testing services across the United States with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified genetic counselors and medical professionals ensures accessible, high-quality care regardless of your location.

Take the Next Step Toward Genetic Clarity

Don’t let uncertainty about genetic conditions affect your family’s future. Our experienced team is ready to guide you through the testing process with compassion and expertise. Contact us today to schedule your genetic counseling session and begin the journey toward definitive answers.

Call or WhatsApp: +1(267) 388-9828 to book your BCS1L Gene GRACILE Syndrome NGS Genetic DNA Test and take control of your genetic health today.